Baptista Research’s Post

Attention GovCon business owners and CEOs! Join us for an exclusive panel discussion on the latest M&A trends, target characteristics, and future market predictions. Secure your spot to gain valuable insights and prepare for your future growth. Don't miss out on this opportunity! https://okt.to/pxOQrb #GovCon #MandA #BusinessGrowth

In this recorded webinar our speaker reviews avenues for improved pharmacogenetic analysis, multivariant analysis using fragment analysis, benefits of cooperative relationships between service providers and health systems. #thermofisheremp

As some are calling GLP-1s the $100 billion answer to a trillion-dollar challenge, listen as equity analyst Ryan Daniels, CFA, partner, expands on the impact these products will have on the healthcare industry from a spending and care delivery perspective, in our latest edition of William Blair Thinking Presents. Listen today: https://lnkd.in/ejzT_HtD #WilliamBlairThinking

Calling all GovCon business owners and CEOs! Get the inside scoop from active GovCon buyers in this panel discussion on the latest M&A trends, target characteristics and predictions for the future market. Don't miss out on this opportunity to prepare for your future sale or gain market intel from active buyers. https://okt.to/6wI7JU #GovCon #MandA #BusinessGrowth

"5 Not-So-Obvious Ways to Reassess Your Healthcare Organization’s Value Analysis Program" 🎧Tune in here: https://lnkd.in/gnBP5d_h // On this week's re-release episode of Power Supply Articles On-the-Go, Bob Yokl discusses why if your value analysis program isn’t a well-oiled machine, it will cost your hospital, system, or IDN time, money, and resources: "With very few exceptions, every hospital, system, and IDN has an active value analysis program to evaluate new purchase requests, review and approve new and renewal group purchasing contracts, and troubleshoot and problem solve product, service, and technology issues. Yet, how many of us have reassessed our healthcare organization’s value analysis program for efficiency and effectiveness..." Tune in to listen to the full article here: https://lnkd.in/gnBP5d_h #PowerSupply #SupplyChain #Healthcare #ValueAnalysis

A year from now you may wish you had started today. Unveiling IDEXX Laboratories' Q2 Earnings: Expectations and Potential for Growth 🏥 #hsa #investing #healthcare #health #family #wellness 🌟 As we eagerly await IDEXX Laboratories' Q2 earnings report next month, analysts are projecting a single-digit bottom-line growth for the renowned healthcare company. With the potential for further expansion in the horizon, now is the perfect time to consider investing in IDEXX Laboratories. H2: Seize the Opportunity, Don't Miss Out on IDEXX Laboratories' Journey to Success! 🚀 Investing in IDEXX Laboratories presents an array of exciting possibilities and the chance to be part of a company that continues to make significant advancements in the healthcare industry. By acting today, you can position yourself to reap the rewards of their anticipated Q2 growth and the potential for even greater success in the future. Embrace the Fear of Missing Out (FOMO) and take action! 💪 The healthcare sector has always presented lucrative investment opportunities, and IDEXX Laboratories is no exception. By investing in this innovative company, you not only contribute to the advancement of healthcare but also maximize the growth potential of your Health Savings Account. Don't let hesitation hold you back. Act now and start capitalizing on the growth of IDEXX Laboratories. Remember, a year from now, you may look back and wish you had seized this opportunity earlier. Begin your journey towards financial wellness and invest in IDEXX Laboratories today! #investing #hsa #healthcare #health #family #wellness 📈🔍💼

Calling all GovCon business owners and CEOs! Get the inside scoop from active GovCon buyers in this panel discussion on the latest M&A trends, target characteristics and predictions for the future market. Don't miss out on this opportunity to prepare for your future sale or gain market intel from active buyers. https://okt.to/mfspTW #GovCon #MandA #BusinessGrowth

Attention Healthcare Supply Chain Leaders! We at HANDLE Global are conducting a brief survey on capital equipment data and sourcing, and we need your expertise! Why Participate? • Only 8 questions • Takes less than 5 minutes • Responses are anonymized • Gain valuable insights on industry trends Your input will help shape the future of capital equipment sourcing and data management in healthcare. Ready to contribute? Click the link below to take the survey! https://lnkd.in/egRnVvnT Thank you for your time and valuable insights!

Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.57 billion for the second quarter ended April 30, 2024, a decline of 8.4% reported and 7.4% core(1) compared to the second quarter of 2023. Second-quarter GAAP net income was $308 million, or $1.05 per share. This compares with $302 million, or $1.02 per share, in the second quarter of fiscal year 2023. Non-GAAP(2) net income was $356 million, or $1.22 per share during the quarter. via Business Wire Health: Medical Devices News

Value Market Research predicts massive growth in the global medical second opinion services market. Read more here: https://lnkd.in/dPDjFmHm #MedicalSecondOpinions #GlobalMarketExpansion #BetterHealthOutcomes